{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:36Z","timestamp":1781650836160,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012957","name":"Friedrich-Schiller-Universit\u00e4t Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Over 10% of all SARS-CoV-2 infections lead to persistent symptoms, a condition called post-COVID condition (PCC). For elite athletes, whose performance is central, PCC poses significant challenges. It is suggested that immune cells, particularly regulatory and effector T cells, play a key role in symptom persistence nonetheless it has not yet been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study investigates immune dynamics after SARS-CoV-2 infection and assesses whether symptom persistence is accompanied by T cell dysregulation in highly trained athletes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-six highly trained athletes were included in this study after experiencing SARS-CoV-2 infection. Athletes\u2019 data were analyzed 2\u20134 weeks after infection (T0) and 3\u20134 months later (T1). They were categorized into two groups: those with persistent symptoms (PS) and those without (SF). Their immune cell distribution was assessed via flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the PS group, there was an increase in T helper (Th) cell 17 and Th2 cells from T0 to T1, whereas in the SF group, these cell types either decreased or remained unchanged, respectively. Furthermore, Th1 cells decreased and natural (NK) cells increased from T0 to T1 in the PS group, while no changes were observed in the SF group. No changes were observed in Tregs nor in other cell types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This dysregulation of the immune system toward humoral immunity indexed by a rise in Th2 and Th17 cells and a decrease in Th1 cells over time could be indicative of a possible virus persistence contributing to persistent symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>The study has been registered in the German Clinical Trials Register (DRKS00023717).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-026-02020-2","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:18:07Z","timestamp":1777295887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune Dysregulation and Persistent Symptoms: Insights into T Cell Dynamics in Post-COVID among Athletes from the CoSmo-S Study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0833-4367","authenticated-orcid":false,"given":"Miriam","family":"Ringleb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-0204","authenticated-orcid":false,"given":"Daniel Alexander","family":"Bizjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-7069","authenticated-orcid":false,"given":"Andreas Michael","family":"Nie\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0565-8130","authenticated-orcid":false,"given":"Hannah","family":"Notbohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-4464","authenticated-orcid":false,"given":"Hans-Georg","family":"Predel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-4605","authenticated-orcid":false,"given":"Christian","family":"Puta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-9450","authenticated-orcid":false,"given":"J\u00fcrgen Michael","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-9920","authenticated-orcid":false,"given":"Manuel","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-5746","authenticated-orcid":false,"given":"Jonas","family":"Zacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-8853","authenticated-orcid":false,"given":"Wilhelm","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-2588","authenticated-orcid":false,"given":"Florian","family":"Javelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2020_CR1","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","volume":"391","author":"EW Ely","year":"2024","unstructured":"Ely EW, Brown LM, Fineberg HV. Long Covid Defined. N Engl J Med. 2024;391:1746\u201353. https:\/\/doi.org\/10.1056\/NEJMsb2408466.","journal-title":"N Engl J Med"},{"key":"2020_CR2","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9.","journal-title":"Lancet Infect Dis"},{"key":"2020_CR3","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16512","author":"M Babicki","year":"2023","unstructured":"Babicki M, Ko\u0142at D, Kapusta J, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Jankowski P, Mastalerz-Migas A, et al. Prevalence and assessment of risk factors among Polish adults with post-COVID syndrome: 12-month follow-up study. Pol Arch Intern Med. 2023. https:\/\/doi.org\/10.20452\/pamw.16512.","journal-title":"Pol Arch Intern Med"},{"key":"2020_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","volume":"23","author":"DM Altmann","year":"2023","unstructured":"Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol [Internet]. 2023;23:618\u201334. https:\/\/doi.org\/10.1038\/s41577-023-00904-7.","journal-title":"Nat Rev Immunol [Internet]"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1136\/bmjgh-2021-005427","volume":"6","author":"M Michelen","year":"2021","unstructured":"Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6:5427. https:\/\/doi.org\/10.1136\/bmjgh-2021-005427.","journal-title":"BMJ Glob Health"},{"key":"2020_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science (1979). 2022;375:1122\u20137. https:\/\/doi.org\/10.1126\/science.abm8108.","journal-title":"Science (1979)"},{"key":"2020_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12931-022-01977-z","volume":"23","author":"B Ribeiro Baptista","year":"2022","unstructured":"Ribeiro Baptista B, d\u2019Humi\u00e8res T, Schlemmer F, Bendib I, Justeau G, Al-Assaad L, et al. Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort. Respir Res. 2022;23:68. https:\/\/doi.org\/10.1186\/s12931-022-01977-z.","journal-title":"Respir Res"},{"key":"2020_CR8","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/v15061370","volume":"15","author":"M Babicki","year":"2023","unstructured":"Babicki M, Kapusta J, Pieniawska-\u015amiech K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Ko\u0142at D, Mastalerz-Migas A, et al. Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register\u201312-Month Follow-Up. Viruses. 2023;15:1370. https:\/\/doi.org\/10.3390\/v15061370.","journal-title":"Viruses"},{"key":"2020_CR9","doi-asserted-by":"publisher","first-page":"e0277984","DOI":"10.1371\/journal.pone.0277984","volume":"17","author":"S Vollrath","year":"2022","unstructured":"Vollrath S, Bizjak DA, Zorn J, Matits L, Jerg A, Munk M, et al. Recovery of performance and persistent symptoms in athletes after COVID-19. PLoS ONE. 2022;17:e0277984. https:\/\/doi.org\/10.1371\/journal.pone.0277984.","journal-title":"PLoS ONE"},{"key":"2020_CR10","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.3390\/jcm10143053","volume":"10","author":"K Komici","year":"2021","unstructured":"Komici K, Bianco A, Perrotta F, Dello Iacono A, Bencivenga L, D\u2019agnano V, et al. Clinical Medicine Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes. J Clin Med. 2021;10:3053. https:\/\/doi.org\/10.3390\/jcm10143053.","journal-title":"J Clin Med"},{"key":"2020_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s40279-023-01976-0","volume":"54","author":"M Widmann","year":"2024","unstructured":"Widmann M, Gaidai R, Schubert I, Grummt M, Bensen L, Kerling A, et al. COVID-19 in Female and Male Athletes: Symptoms, Clinical Findings, Outcome, and Prolonged Exercise Intolerance\u2014A Prospective, Observational, Multicenter Cohort Study (CoSmo-S). Sports Med. 2024;54:1033\u201349. https:\/\/doi.org\/10.1007\/s40279-023-01976-0.","journal-title":"Sports Med"},{"key":"2020_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol [Internet]. 2021;93:250\u20136. https:\/\/doi.org\/10.1002\/jmv.26232.","journal-title":"J Med Virol [Internet]"},{"key":"2020_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. Lancet Publishing Group. 2020;395:1033\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0.","journal-title":"Lancet Publishing Group"},{"key":"2020_CR14","doi-asserted-by":"publisher","unstructured":"Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J BioMed Cent Ltd. 2022;19. https:\/\/doi.org\/10.1186\/s12985-022-01814-1.","DOI":"10.1186\/s12985-022-01814-1"},{"key":"2020_CR15","doi-asserted-by":"publisher","unstructured":"Garcia-Gasalla M, Berman-Riu M, Pons J, Rodr\u00edguez A, Iglesias A, Mart\u00ednez-Pomar N, et al. Hyperinflammatory state and low T1 adaptive immune response in severe and critical acute COVID-19 patients. Front Med (Lausanne). Front Media S A. 2022;9. https:\/\/doi.org\/10.3389\/fmed.2022.828678.","DOI":"10.3389\/fmed.2022.828678"},{"key":"2020_CR16","doi-asserted-by":"publisher","unstructured":"Gil-Etayo FJ, Garcinu\u00f1o S, Utrero-Rico A, Cabrera-Marante O, Arroyo-Sanchez D, Mancebo E, et al. An early Th1 response is a key factor for a favorable COVID-19 evolution. Biomedicines MDPI. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10020296.","DOI":"10.3390\/biomedicines10020296"},{"key":"2020_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1034\/j.1600-065X.2000.00607.x","volume":"176","author":"Q Vos","year":"2000","unstructured":"Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev Blackwell Munksgaard. 2000;176:154\u201370. https:\/\/doi.org\/10.1034\/j.1600-065X.2000.00607.x.","journal-title":"Immunol Rev Blackwell Munksgaard"},{"key":"2020_CR18","doi-asserted-by":"publisher","unstructured":"Haunhorst S, Bloch W, Javelle F, Kr\u00fcger K, Baumgart S, Drube S, et al. A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients \u2013 indications for their potential involvement in the development of Long COVID? Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1070994.","DOI":"10.3389\/fimmu.2022.1070994"},{"key":"2020_CR19","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/biomedicines9111540","volume":"9","author":"A Utrero-Rico","year":"2021","unstructured":"Utrero-Rico A, Ruiz-Ruig\u00f3mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz\u00e1lez-Cuadrado C, et al. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID. Biomedicines. 2021;9:1540. https:\/\/doi.org\/10.3390\/biomedicines9111540.","journal-title":"Biomedicines"},{"key":"2020_CR20","doi-asserted-by":"publisher","unstructured":"Gal\u00e1n M, Vig\u00f3n L, Fuertes D, Murciano-Ant\u00f3n MA, Casado-Fern\u00e1ndez G, Dom\u00ednguez-Mateos S, et al. Persistent overactive cytotoxic immune response in a spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.848886.","DOI":"10.3389\/fimmu.2022.848886"},{"key":"2020_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235\u20138. https:\/\/doi.org\/10.1038\/nature04753.","journal-title":"Nature"},{"key":"2020_CR22","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.psyneuen.2021.105295","volume":"131","author":"N Kappelmann","year":"2021","unstructured":"Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131:105295. https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105295.","journal-title":"Psychoneuroendocrinology"},{"key":"2020_CR23","doi-asserted-by":"publisher","first-page":"596553","DOI":"10.3389\/fimmu.2020.596553","volume":"11","author":"JF Guti\u00e9rrez-Bautista","year":"2020","unstructured":"Guti\u00e9rrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, Jim\u00e9 Nez P, Garrido F, Anderson P, et al. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset. Front Immunol [Internet]. 2020;11:596553. https:\/\/doi.org\/10.3389\/fimmu.2020.596553.","journal-title":"Front Immunol [Internet]"},{"key":"2020_CR24","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/eji.200939688","volume":"39","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol. 2009;39:2331\u20136. https:\/\/doi.org\/10.1002\/eji.200939688.","journal-title":"Eur J Immunol"},{"key":"2020_CR25","first-page":"13","volume":"05","author":"MD Beekley","year":"2006","unstructured":"Beekley MD, Abe T, Kondo M, Midorikawa T, Yamauchi T. Comparison Of Normalized Maximum Aerobic Capacity And Body Composition Of Sumo Wrestlers To Athletes In Combat And Other Sports. J Sports Sci Med. 2006;05:13\u201320.","journal-title":"J Sports Sci Med"},{"key":"2020_CR26","doi-asserted-by":"publisher","unstructured":"Niess AM, Widmann M, Gaidai R, G\u00f6lz C, Schubert I, Castillo K, et al. COVID-19 in german competitive sports: protocol for a prospective multicenter cohort study (CoSmo-S). Int J Public Health. 2022;67. https:\/\/doi.org\/10.3389\/ijph.2022.1604414.","DOI":"10.3389\/ijph.2022.1604414"},{"key":"2020_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-0033-1343395","volume":"121","author":"P Wenning","year":"2013","unstructured":"Wenning P, Kreutz T, Schmidt A, Opitz D, Graf C, Voss S, et al. Endurance Exercise Alters Cellular Immune Status and Resistin Concentrations in Men Suffering from Non-insulin-dependent Type 2 Diabetes. Exp Clin Endocrinol Diabetes. 2013;121:475\u201382. https:\/\/doi.org\/10.1055\/s-0033-1343395.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020_CR28","doi-asserted-by":"publisher","unstructured":"Hussein HAM, Thabet AA, Wardany AA, El-Adly AM, Ali M, Hassan MEA, et al. SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression. Virol J BioMed Cent Ltd. 2024;21. https:\/\/doi.org\/10.1186\/s12985-024-02342-w.","DOI":"10.1186\/s12985-024-02342-w"},{"key":"2020_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22031308","volume":"22","author":"NA Wong","year":"2021","unstructured":"Wong NA, Saier MH. The sars-coronavirus infection cycle: A survey of viral membrane proteins, their functional interactions and pathogenesis. Int J Mol Sci MDPI AG. 2021;22:1\u201363. https:\/\/doi.org\/10.3390\/ijms22031308.","journal-title":"Int J Mol Sci MDPI AG"},{"key":"2020_CR30","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhang Y, Gu W, Sun B. Th1\/Th2 cell differentiation and molecular signals. 2014;15\u201344. https:\/\/doi.org\/10.1007\/978-94-017-9487-9_2.","DOI":"10.1007\/978-94-017-9487-9_2"},{"key":"2020_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0952-7915(97)80154-9","volume":"9","author":"G Trinchieri","year":"1997","unstructured":"Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-\u03b3). Curr Opin Immunol. 1997;9:17\u201323. https:\/\/doi.org\/10.1016\/S0952-7915(97)80154-9.","journal-title":"Curr Opin Immunol"},{"key":"2020_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08830180902978120","volume":"28","author":"F Zhou","year":"2009","unstructured":"Zhou F. Molecular Mechanisms of IFN-\u03b3 to Up-Regulate MHC Class I Antigen Processing and Presentation. Int Rev Immunol. 2009;28:239\u201360. https:\/\/doi.org\/10.1080\/08830180902978120.","journal-title":"Int Rev Immunol"},{"key":"2020_CR33","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.4049\/jimmunol.167.10.5574","volume":"167","author":"GZ Tau","year":"2001","unstructured":"Tau GZ, Cowan SN, Weisburg J, Braunstein NS, Rothman PB. Regulation of IFN-\u03b3 Signaling Is Essential for the Cytotoxic Activity of CD8\u2009+\u2009T Cells. J Immunol. 2001;167:5574\u201382. https:\/\/doi.org\/10.4049\/jimmunol.167.10.5574.","journal-title":"J Immunol"},{"key":"2020_CR34","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1128\/JVI.74.16.7470-7477.2000","volume":"74","author":"M Li","year":"2000","unstructured":"Li M, Beg AA. Induction of Necrotic-Like Cell Death by Tumor Necrosis Factor Alpha and Caspase Inhibitors: Novel Mechanism for Killing Virus-Infected Cells. J Virol. 2000;74:7470\u20137. https:\/\/doi.org\/10.1128\/JVI.74.16.7470-7477.2000.","journal-title":"J Virol"},{"key":"2020_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/TP.0b013e318270f3c0","volume":"94","author":"JM Zimmerer","year":"2012","unstructured":"Zimmerer JM, Horne PH, Fiessinger LA, Fisher MG, Pham TA, Saklayen SL, et al. Cytotoxic Effector Function of CD4-Independent, CD8\u2009+\u2009T Cells Is Mediated by TNF-\u03b1\/TNFR. Transplantation. 2012;94:1103\u201310. https:\/\/doi.org\/10.1097\/TP.0b013e318270f3c0.","journal-title":"Transplantation"},{"key":"2020_CR36","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","volume":"117","author":"SM Opal","year":"2000","unstructured":"Opal SM, DePalo VA, Anti-Inflammatory Cytokines. Chest. 2000;117:1162\u201372. https:\/\/doi.org\/10.1378\/chest.117.4.1162.","journal-title":"Chest"},{"key":"2020_CR37","doi-asserted-by":"publisher","unstructured":"Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. The role of th17 response in COVID-19. Cells. MDPI; 2021. https:\/\/doi.org\/10.3390\/cells10061550.","DOI":"10.3390\/cells10061550"},{"key":"2020_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec P, Kolls JK. Targeting IL-17 and T H 17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11:763\u201376. https:\/\/doi.org\/10.1038\/nrd3794.","journal-title":"Nat Rev Drug Discov"},{"key":"2020_CR39","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1111\/all.16210","volume":"79","author":"B Kratzer","year":"2024","unstructured":"Kratzer B, Gattinger P, Trapin D, Ettel P, K\u00f6rm\u00f6czi U, Rottal A, et al. Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1\/inflammatory to Th2 serum cytokine levels long after first COVID-19. Allergy: European Journal of Allergy and Clinical Immunology. John Wiley Sons Inc. 2024;79:2482\u2013501. https:\/\/doi.org\/10.1111\/all.16210.","journal-title":"John Wiley Sons Inc"},{"key":"2020_CR40","doi-asserted-by":"publisher","unstructured":"Claus M, Pieris N, Urlaub D, Br\u00f6de P, Schaaf B, Durak D, et al. Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection. Front Cell Infect Microbiol Front Media SA. 2023;13. https:\/\/doi.org\/10.3389\/fcimb.2023.1266790.","DOI":"10.3389\/fcimb.2023.1266790"},{"key":"2020_CR41","doi-asserted-by":"publisher","unstructured":"Tsao T, Buck AM, Grimbert L, LaFranchi BH, Altamirano Poblano B, Fehrman EA, et al. Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes. J Clin Invest [Internet]. 2025;135. https:\/\/doi.org\/10.1172\/JCI188182.","DOI":"10.1172\/JCI188182"},{"key":"2020_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nri.2017.118","volume":"18","author":"JA Walker","year":"2018","unstructured":"Walker JA, McKenzie ANJ. TH2 cell development and function. Nat Rev Immunol. 2018;18:121\u201333. https:\/\/doi.org\/10.1038\/nri.2017.118.","journal-title":"Nat Rev Immunol"},{"key":"2020_CR43","doi-asserted-by":"publisher","unstructured":"Chen J, Yao J. Th22 cells and the intestinal mucosal barrier. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1221068.","DOI":"10.3389\/fimmu.2023.1221068"},{"key":"2020_CR44","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/biology13110948","volume":"13","author":"M Grau","year":"2024","unstructured":"Grau M, Presche A, Kr\u00fcger A-L, Bloch W, Haiduk B. Red Blood Cell Morphology Is Associated with Altered Hemorheological Properties and Fatigue in Patients with Long COVID. Biology (Basel). 2024;13:948. https:\/\/doi.org\/10.3390\/biology13110948.","journal-title":"Biology (Basel)"},{"key":"2020_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1126\/science.abm0811","volume":"375","author":"CJ Reynolds","year":"2022","unstructured":"Reynolds CJ, Gibbons JM, Pade C, Lin K-M, Sandoval DM, Pieper F, et al. Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants. Science. 2022 (1979);375:183\u201392. https:\/\/doi.org\/10.1126\/science.abm0811.","journal-title":"Science (1979)"},{"key":"2020_CR46","doi-asserted-by":"publisher","first-page":"e23596","DOI":"10.1096\/fj.202301619R","volume":"38","author":"M Ringleb","year":"2024","unstructured":"Ringleb M, Javelle F, Haunhorst S, Bloch W, Fennen L, Baumgart S, et al. Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise \u2013 A systematic review and meta-analysis. FASEB J. 2024;38:e23596. https:\/\/doi.org\/10.1096\/fj.202301619R.","journal-title":"FASEB J"},{"key":"2020_CR47","doi-asserted-by":"publisher","unstructured":"Ringleb M, Fabritius F, Godde J, Puta C, Bloch W, Javelle F. Circulating Myokine Responses to Acute Endurance Exercise and Their Role in Immunoregulation: A Systematic Review and Meta\u2010Analysis. FASEB J. 2026;40(4):e71536. https:\/\/doi.org\/10.1096\/fj.202504780R","DOI":"10.1096\/fj.202504780R"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02020-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:46Z","timestamp":1781650126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02020-2","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained by the Ethics Committee of the Medical Faculty, University of T\u00fcbingen on 28 July 2020 (reference number: 608\/2020BO1), the Ethics Committee of the University of Ulm on 3 November 2020 (reference number: 408\/20), and the Ethics Commit-tee of the German Sport University Cologne on 22 June 2020 (reference number: 087\/2020). The work described is carried out following the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained for any experimentation with human subjects including human volunteers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Written informed consent was required from all participants. For those under 18, parental consent was also necessary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}